XML 46 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of significant accounting policies (Details 3) (USD $)
12 Months Ended 0 Months Ended
Dec. 31, 2014
Dec. 31, 2012
Mar. 07, 2013
Research and development costs      
Deferred research and development advance payments $ 900,000ptct_DeferredResearchAndDevelopmentCosts    
Beneficial conversion      
Beneficial conversion charge   378,000us-gaap_PreferredStockConversionsInducements  
Impairment of long-lived assets      
Impairment of long-lived assets 0us-gaap_AssetImpairmentCharges    
Income Tax Expense (Benefit), Continuing Operations [Abstract]      
Net tax benefit 4,693,000us-gaap_IncomeTaxExpenseBenefit    
New Jersey      
Income Tax Expense (Benefit), Continuing Operations [Abstract]      
Net tax benefit $ 4,900,000us-gaap_IncomeTaxExpenseBenefit
/ us-gaap_StatementGeographicalAxis
= stpr_NJ
   
Common stock      
Reverse Stock Split [Abstract]      
Reverse stock split ratio     0.0083us-gaap_StockholdersEquityNoteStockSplitConversionRatio1
/ us-gaap_StatementClassOfStockAxis
= us-gaap_CommonStockMember